Friday was a psychedelic day for me as all three panels I attended covered current research into the use of psychedelics for cognitive, behavioral, and psychological treatment for systems ranging from end-of-life anxiety, schizophrenia, obsessive-compulsive disorder (OCD), anorexia, cancer, depression, and addictive disorders.